biotech / news / / Bloomberg
Isomorphic Labs, an AI-powered drug discovery company, is in advanced discussions to raise more than $2 billion in a new round of funding.
Isomorphic Labs is in advanced talks to raise over $2 billion in new funding.
KEY POINTS
- Thrive Capital is leading this upcoming financing round for Isomorphic Labs.
- Alphabet is participating in this funding round, but it has not yet been finalized.
- This new round follows Thrive Capital's leadership in Isomorphic's first fundraising last year.
COMPANIES
Summarized by Newsio from Bloomberg. How we summarize →